Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Half of Germany's doctors oppose DMPs (disease management programmes)

This article was originally published in Clinica

Executive Summary

Proposals by a number of Germany's regional doctors' associations (KVs) to boycott the health ministry's proposed disease management programmes (DMPs) will not only question the quality assurance of the programmes, but also prevent some of the regions from benefiting from the statutory health insurers' fund balancing mechanism, claims the companies' sickness fund, the BKK. The DMPs, two of which started on July 1, are aimed at providing optimal care to the chronically ill. They are seen as being beneficial to industry as the programmes will ensure that devices are used within the certain time frame for the diseases in question (see Clinica No 995, p 6).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067236

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel